第14卷第1期器官移植Vol.14 No.12023年1月Organ TransplantationJan.2023·指南与共识·中国实体器官移植手术部位感染管理专家共识（2022版)中国医师协会器官移植医师分会中华医学会器官移植学分会【摘要】近年来，我国实体器官移植事业蓬勃发展，移植数量和疗效均显著提升。手术部位感染($SI)仍是影响实体器官移植受者生存的重要因素。本共识聚焦S$I管理基本原则、流行病学与危险因素、特殊病原体感染管理和诊断技术等方面内容，汇聚全国器官移植学、感染病学、重症医学、检验医学和临床药学等多学科专家意见，系统阐述我国器官移植SSI管理相关经验，旨在规范各移植中心SSI的防控措施，降低我国实体器官移植术后S$I的发生率和病死率。【关键词】实体器官移植；手术部位感染；诊断；治疗；专家共识【中图分类号】R617,R619+.3【文献标志码】A【文章编号】16747445(2023)01-0002-14Chinese experts consensus on the management of surgical site infection in solid organ transplantation (2022 edition)Branch ofOrgan Transplant Physicians of Chinese Medical Doctor Association,Branch of Organ Transplantation of Chinese Medical Association.School of Medicine.Zhejiang University:the Center for Integrated Oncology and Intelligent Medicine ofZhejiang Province,Institute of OrganTransplantation of Zhejiang University.Hangzhou 310006.ChinaAbstract]The quality of solid organ transplantation has been improved significantly in China in recent years.However,surgical site infection (SSI)is still a main factor affecting the survival of solid organ transplantation recipients.With the joint efforts of experts in fields of organ transplantation,infectious diseases,critical care medicine,laboratorymedicine and clinical pharmacy,this expert consensus systematically summarizes the experiences of SSI management insolid organ transplantation in China,focusing on basic management principles,epidemiology,risk factors,special pathogeninfection and diagnostic techniques of SSI.It aims to standardize the prevention measures of SSI in transplantation centersto reduce the incidence and mortality of SSI in solid organ transplantation recipients.[Key words]Solid organ transplantation;Surgical site infection;Diagnosis,Treatment;Experts consensus手术部位感染(surgical site infection,SSI)是指者住院时间延长及死亡的重要原因，须引起重视。发生在手术切口浅部和深部组织、手术器官或腔隙的感染口。作为实体器官移植受者术后早期感染的主要1SSI简介与基本原则形式，SSI发生率为3.0%~53.0%，高于普通手术患者1.1诊断(3.0%-32.7%)-。SSI是导致实体器官移植术后受实体器官移植SSI的诊断需在移植后30d内（有D0L:10.3969j.issn.16747445.2023.01.002基金项目：国家自然科学基金重点项目(81930016)：国家自然科学基金重大研究计划(92159202)：国家重点研发计划“干细胞研究与器官修复”重点专项(2021YFA1100500):浙江省重点研发计划(2019C03050、2022C03108)执笔作者单位：310006杭州。浙江大学医学院浙江省肿瘤融合研究与智能医学实验室浙江大学器官移植研究所
